# New Science Ventures

New Science Ventures is a Venture Capital based in Greenwich, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Greenwich, United States
- **Region:** North America
- **Address:** 500 West Putnam Avenue, Suite 400, Greenwich, CT 06830, United States
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** www.newscienceventures.com
- **LinkedIn:** https://www.linkedin.com/company/new-science-ventures

## Regulatory record

- **Reports private funds:** No

## About

New Science Ventures is a venture capital firm investing in early and late-stage companies in Life Sciences and Information Technology sectors. Their investments include pharmaceuticals, biologics, medical devices, diagnostics, high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage. New Science Ventures has made 154 investments and facilitated 23 portfolio exits.

## Sectors

- Life Sciences
- Information Technology
- Deep Tech
- ClimateTech

## Offices

- London, United Kingdom

## People

- Andrew Abrams — Partner

## Questions

### How does New Science Ventures source proprietary deal flow?

NSV sources by going where the science is, deliberately targeting companies outside traditional tech and biotech hubs. It leverages the deep scientific networks of its investment team, which includes professionals with advanced degrees and direct industry experience. The firm emphasizes fundamental, science-based innovation with strong IP protection, often taking contrarian views that conventional VCs overlook.

### Does New Science Ventures lead rounds or co-invest?

NSV is explicitly flexible: it is willing to lead, follow, or serve as the sole investor in a round. This posture allows the firm to assemble the right syndicate for each company's stage and context. It does not require a minimum co-investor structure and can act unilaterally when it identifies a high-conviction, science-driven opportunity.

### What investment stages does New Science Ventures target?

The firm invests across early-stage (including seed and start-up) and late-stage expansion. This broad mandate reflects its focus on supporting companies through value inflection points. The stage is tailored to the scientific maturity and capital needs of each opportunity.

### Which sectors does New Science Ventures actively invest in?

NSV concentrates on life sciences and information technology. Specific sub-sectors evident in the portfolio include novel therapeutics, advanced materials (graphene electronics), satellite-based weather data, automated transit, 5G private networks, and radiation-hardened space chips. The common thread is science-based innovation addressing significant unmet needs.

### Who leads investment decisions at New Science Ventures?

Decision-making authority rests with the investment team, which includes Partner Andrew Abrams working from the London office. The firm operates with a lean structure; final investment decisions are made by the partnership, drawing on collective board-level and scientific expertise.

### What is New Science Ventures' geographic footprint?

NSV operates a transatlantic model with offices in Greenwich, Connecticut and London. Its portfolio spans the United States and Europe, with confirmed companies in the UK, continental Europe, and the US. The firm explicitly invests outside traditional tech and life-science hubs.

## Related profiles

- [NewSchools Venture Fund](https://altss.com/profile/newschools-venture-fund)
- [Newsight Tech Angels](https://altss.com/profile/newsight-tech-angels)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/new-science-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology